Hosted by Dailymotion. For legal issues report at the Copyright Center, report us on DMC, or use the Instant Removal tool.
Why Moderna Shares Are Ripping Higher
Description
Moderna ($MRNA@US) was trading higher Monday following the company's pipeline update at the JP Morgan ($JPM@US) Healthcare Conference. Moderna announced that it now has 40 programs in development, including 23 in ongoing clinical studies, encompassing mRNA infectious disease vaccines and mRNA therapeutics spanning seven different modalities. Stéphane Bancel, CEO of Moderna, said that "While our COVID-19 vaccine is our first medicine to market, we have made significant progress across our pipeline of 40 development programs and now have 23 mRNA programs in clinical trials.” Moderna also announced a collaboration with Carisma Therapeutics for cancer treatment. The collaboration aims to discover, develop and commercialize in vivo engineered chimeric antigen receptor monocyte therapeutics. Carisma will find development candidates while Moderna will lead the development and commercialization of viable options. The company said it expects 2021 product sales of over $17 billion. Moderna shares were up about 9%.
Keywords & Tags
#covid
#Infectious Disease
#vaccine
#COVID-19
#CEO
#covid 19
#pandemic
#Moderna
#pipeline
#MRNA
#JP Morgan
#collaboration
#vaccination
#medical
#clinical trials
#cancer treatment
#variant
#mandate
#death rate
#hospitalization
#masks
#hospitals
#Shares Are Higher
#Healthcare Conference
#clinical studies
#mRNA therapeutics
#Stéphane Bancel
#Carisma Therapeutics
#in vivo engineered
#chimeric antigen receptor monocyte therapeutics
More from User
00:58
SAVE Exit Deadline
Benzinga
00:51
Alibaba Bans Claude Tools
Benzinga
00:52
Rivian Stock Slides
Benzinga
00:56
Bitcoin Bottom Debate
Benzinga
00:57
Quarterly Reports Defended
Benzinga
00:52
China's Gig Work Strain
Benzinga
Related Videos
00:44
Vaccin anti-Covid: le PDG de Moderna, Stéphane Bancel, "confirme une efficacité à 94%"
BFM
01:10
Stéphane Bancel, patron de Moderna, ambitionne de proposer très rapidement un vaccin contre le Covid-19
BFM
00:54
Vaccin anti-Covid: Stéphane Bancel (Moderna) pense que les personnes vaccinées seront protégées pendant "au moins 6 à 12 mois"
BFM
01:47
Stéphane Bancel (Moderna) sur la vaccination anti-Covid: "Nous sommes convaincus scientifiquement que des rappels vont être importants"
BFM
07:35
India Gives Nod To Moderna mRNA Covid-19 Vaccine, Cipla To Import Under Emergency Use
LatestLY
03:25
Moderna Shares Traded Higher Tuesday Following An Upgrade From Oppenheimer: What Investors Need To Know
Benzinga